Background: Although a number of growth factors bind cell-surface heparan sulphate proteoglycans (HSPGs), the role of this interaction is unclear except for fibroblast growth factor which requires HSPG binding for signalling. Hepatocyte growth factor/scatter factor (HGF/SF) plays important roles in mammalian development and tissue regeneration and acts on target cells through a specific receptor tyrosine kinase encoded by the c-met protooncogene. This factor also binds HSPGs with high affinity, but conflicting data have been reported on the role of HSPG binding in HGF/SF signalling.
Background
Polypeptide growth factors are known to exert their effects on target cells by binding to specific membrane receptors [1] . However, it has become clear in recent years that a number of these proteins also bind cell-surface and matrix proteoglycans, especially those of the heparan sulphate variety (HSPGs). The biological significance of this dual interaction is well understood in the case of fibroblast growth factor (FGF): cells expressing the FGF receptor but lacking membrane-bound heparan sulphate fail to respond to basic FGF [2, 3] , suggesting that heparan sulphate is an essential co-receptor for FGF signalling. Other growth factors, such as the epidermal growth factor (EGF)-related polypeptides amphiregulin [4] and heparin-binding EGF (HB-EGF) [5] , as well as several splice variants of vascular endothelial growth factor (VEGF) [6] also require cell-bound heparan sulphate for activity, although the role of HSPGs in these systems is less defined.
Hepatocyte growth factor/scatter factor (HGF/SF) [7] [8] [9] [10] [11] [12] is a high molecular weight polypeptide growth factor with a domain structure related to that of the blood proteinase precursor plasminogen. Like plasminogen, HGF/SF is produced as an inactive, single-chain polypeptide which is converted proteolytically into an active two-chain species [13] [14] [15] . This form of HGF/SF induces growth, movement and differentiation in target cells via a specific membrane tyrosine-kinase receptor encoded by the c-met proto-oncogene [16, 17] . HGF/SF binds tightly to the Met receptor with a molar dissociation constant (K d ) in the sub-nanomolar range [18, 19] . HGF/SF also binds heparin [20, 21] , a densely sulphated glycosaminoglycan that resembles the carbohydrate side chains of HSPGs. Binding to heparin does not appear to affect the affinity of HGF/SF for a soluble form of the Met receptor although it does increase receptor phosphorylation and mitogenicity on target cells [22] . HGF/SF-heparin complexes also have sustained plasma levels and reduced hepatic clearance in vivo [23] .
The modular structure of HGF/SF has facilitated the identification of the domains responsible for binding to the receptor and to heparin. Deletion of the hairpin structure of the amino-terminal domain (a domain homologous to the activation peptide of plasminogen) or kringle 2 (a globular domain with a characteristic triple-looped structure) results in mutants with reduced apparent affinities for heparin [24] . By contrast, deletion of kringle 1, 3 or 4 or the proteinase domain, has little or no effect [24] . Thus, the heparin-binding site(s) of HGF/SF appear to be contained in the hairpin structure of the amino-terminal domain and kringle 2. The same domains, however, are also critical for Met binding and signalling [25] [26] [27] [28] .
In order to dissect the binding sites for Met and heparin in HGF/SF, we generated three-dimensional models of the individual domains [29] to help to design a number of sitespecific HGF/SF mutants. The available X-ray structures of antithrombin [30] and FGF-heparin complexes [31] indicate that heparin-binding sites are composed primarily of clusters of positively charged residues making electrostatic contact with negatively charged groups in the glycosaminoglycan. We therefore searched the surface of the hairpin structure and kringle 2 of HGF/SF for clusters of positively charged amino acids, identified three such clusters (two in the hairpin structure and one in kringle 2) and introduced specific mutations at these sites.
Results

Hairpin structure and kringle 2 mutants of HGF/SF
The amino-terminal domain of HGF/SF contains four cysteine residues that are conserved in the HGF/SF homologues hepatocyte growth factor-like/macrophage-stimulating protein (HGFl/MSP) and plasminogen. Studies of plasminogen [32] indicate that this domain forms a hairpin structure stabilised by two disulphide bonds. A threedimensional model of the hairpin structure of HGF/SF suggested the presence of several positively charged residues that were absent in the corresponding models of HGFl/MSP and plasminogen [29] . Six different point mutants of the hairpin structure of HGF/SF were constructed (HP1-HP6) in which a total of 10 amino acid residues were substituted. The strategy involved mutation of positively charged amino acids to negative, negative to positive and hydrophobic to polar (Figure 1a) . The activity of these point mutants was compared with that of wildtype (wt) HGF/SF and HP∆, a mutant in which the whole hairpin structure (amino acids 68-100) was deleted. In addition, two multiple mutants of kringle 2 were constructed (Figure 1b) . In the Kr2-1 mutant, a cluster of four positive residues on the surface of the kringle (H241, R242, K244 and R249, using single-letter amino-acid code) was mutated; in the Kr2-2 mutant, three residues were mutated that had been predicted either to form part of a hydrophobic pocket on the surface of kringle 2 (W282 and Y284) or to establish hydrogen bonds with a lysine residue bound within the pocket (R281) [29] .
For initial studies, mutants were expressed by transient transfection into the Neuro 2a cell line ( Figure 2a ) and characterised for heparin binding (Figure 2b ) and biological activity ( Figure 2c ). As expected, HP∆, the mutant lacking the hairpin structure, exhibited neither heparin binding nor biological activity. The point mutants were categorised into three different groups: group 1 (HP1, HP2 and HP4) had normal signalling activity but a greatly 126 Current Biology, Vol 8 No 3
Figure 1
Distribution of the electrostatic potential in (a) the hairpin structure and (b) the kringle 2 of HGF/SF and the mutations introduced into these regions. The electrostatic potential on the solvent-accessible surface of the two HGF/SF domains is shown by a colour code ranging from yellow (strong positive charge) to blue (strong negative charge) using the molecular interactive display and simulation (MIDAS) software (UCSF) and the atomic coordinates of previously generated threedimensional models [29] . The mutations introduced into the hairpin structure and into kringle 2 are also shown. HP1: R73E, R76E, R93E  HP2: R73E, R76E, K78E  HP3: K91D, R93E, K94D  HP4: L80S, F82Q  HP5: K85E  HP6: D90K   Kr2-1: H241S, R242E, K244E, R249G  Kr2-2: R281G, W282A, Y284A   K244   R249   R242   H241  R73   R76 
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Current Biology decreased (HP1 and HP2) or a moderately decreased (HP4) heparin-binding ability; group 2 (HP3) showed a severe loss of both signalling and heparin-binding activity; and group 3 (HP5 and HP6) behaved essentially like wildtype HGF/SF (Figure 2b ,c). The first kringle 2 mutant, Kr2-1, showed severely reduced levels of heparin binding and biological activity whereas the second one, Kr2-2, was indistinguishable from wt-HGF/SF (Figure 2b,c) . From these results, we can conclude that the first cluster of positively charged residues in the hairpin structure (R73, R76) is involved in binding to heparin but not to Met and that residues R281, W282 and Y284 are not involved in either process. It also appears that two extra clusters of positively charged residues, one in the hairpin structure (K91 and K94) and one in kringle 2 (H241, R242, K244 and R249) may participate in binding to both Met and heparin. Sensorgram overlays of the binding of wt-NK2 ( Figure 3a ) and HP1-NK2 (Figure 3b ) to heparin confirmed that these fragments had major differences in heparin binding. For wt-NK2, the dissociation curves were slower at the higher concentrations and apparent k off values varied between 1 and 4 × 10 -3 sec -1 ( Figure 3c ). In contrast, the dissociation of HP1-NK2 ( Figure 3b ) rose with concentration to an apparent k off value of 6-7 × 10 -3 sec -1 ( Figure 3c ). Analysis of the association phase of wt-NK2 (Figure 3a) showed complex kinetics. Assuming a single class of binding sites The data are expressed as a percentage relative to wt-HGF/SF, which is designated as having 100% activity. Deletion of the hairpin structure (residues 68-100; HP∆) reduced heparin binding to less than 5%. Similarily, all mutants in which basic amino acid residues were exchanged (HP1, HP2, HP3) showed strongly reduced heparin binding. Mutations outside the positively charged surface (HP4, HP5, HP6) either had a less pronounced effect (HP4) or no effect (HP5 and HP6). Substitution of positively charged amino acids on the surface of kringle 2 (Kr2-1) reduced heparin binding to 18% of wt-HGF/SF activity, whereas deletion of the lysine-binding pocket (Kr2-2) had no effect. (c) Scatter of MDCK colonies by wild-type and mutant HGF/SFs. The data are expressed as a percentage of wt-HGF/SF, which is designated as having 100% activity. Deletion of the hairpin structure (HP∆) abolished biological activity but point mutations of positively charged amino acids in the hairpin structure had variable effects. The two kringle 2 mutants either showed a severe loss of activity (Kr2-1) or no change (Kr2-2). and taking data from the earliest (fastest) phase, plots of the observed association rate constant ('K s ') against concentration for concentrations up to 300 nM gave a straight line (r 2 = 0.997) from which we calculated k on to be 1.75 × 10 6 M -1 sec -1 ( Figure 3d ). In the later stages of binding, a second phase showing much slower association was discernible but attempts to fit models that proposed two distinct classes of binding sites were unsuccessful. Taking the fastest value for k off to be 4 × 10 -3 sec -1 and a value for k on to be 1.75 × 10 6 M -1 sec -1 , a K d of 2.3 nM was calculated for wt-NK2. For HP1-NK2, analysis of the early phase of binding (assuming the presence of a single class of binding sites) gave a k on value of approximately 5 × 10 4 M -1 sec -1 from the plot of K S against concentration ( Figure 3d ). This figure was approximately 35-fold lower than that for wt-NK2. Taking a value of 6 × 10 -3 sec -1 for k off (Figure 3c ), a K d of 120 nM was calculated for HP1-NK2. The binding affinity of HP1-NK2 is therefore more than 50-fold lower than that of wt-NK2.
Control
Binding of wt-HGF/SF and HP1 to HSPGs
The binding of wt-HGF/SF and HP1 to cell-surface and matrix heparan sulphates was investigated in several cell types, including the carcinoma lines HepG2 and Hep3B and mink lung cells. The latter have recently been shown to bind large amounts of HGF/SF and its truncated forms NK1 and NK2 via HSPGs [33] . By immunofluorescence, the total binding of HP1 to HepG2 and Hep3B cells was much lower than for wt-HGF/SF (compare for Hep3B cells). These results were confirmed and extended by a quantitative solid-phase assay and a representative experiment illustrating the binding of full length wt-HGF/SF and HP1 to mink lung cells is shown in Figure 5 . The total binding of wt-HGF/SF to mink lung cells increased steadily from 10 to 675 ng/ml whereas binding of HP1 was hardly measurable over the same range of concentrations. Exogenous heparin (0.1 mg/ml) competed effectively for the binding of wt-HGF/SF to the cells and reduced this binding to levels only slightly higher than those for HP1.
Binding of wt-HGF/SF and HP1 to Met and activity on target cells in culture
In ]-labelled wt-HGF/SF and HP1 in rat tissues. Two hours after injection, two animals were sacrificed and, after perfusion, several organs (liver, kidney, lung, heart, testis and spleen) were homogenised and the amount of TCA-insoluble radioactivity measured. The level of tissue radioactivity was 2-3-fold higher for HP1 than for wt-HGF/SF, although the pattern of organ distribution was the same with the two proteins. (c) Stimulation of DNA synthesis in mouse liver by wt-HGF/SF and HP1. The wt-HGF/SF and HP1 proteins were administered intravenously over a period of 3 days (total dose 277.5 µg per animal distributed over the course of five injections). At the time that the animals received the last dose of factor, bromodeoxyuridine (BrdU) was injected intraperitoneally (75 µg/g body weight), and 12 h later the animals were sacrificed. BrdU-labelled cells were counted on frozen liver sections (at least 8 different sections and a total of 120 fields per animal). Data are the mean ± s.d. for four (wt-HGF/SF) or three (HP1) animals.
first 15 minutes). The clearance of HP1 was much slower and, at every time point tested, the concentration of HP1 in plasma was 5-10-fold higher than wt-HGF/SF for up to 20 hours after injection (Figure 8a ).
The slower clearance of HP1 from serum was associated with an increased amount of the mutant factor in several organs including liver, kidney, lung, heart, testis and spleen (Figure 8b ). The relative distribution of the HP1 mutant and wt-HGF/SF in different organs was similar but the concentration of HP1 in these organs was 2-3-fold higher than wt-HGF/SF (Figure 8b ). The ability of wt-HGF/SF to induce DNA synthesis in adult liver was then investigated after intravenous injection of the two proteins. As expected, in the absence of factors, DNA synthesis was very low but increased considerably after administration of either HGF/SF or HP1 (Figure 8c ). However, stimulation by HP1 was 2.7-fold higher than for wt-HGF/SF (Figure 8c ), in agreement with the increased level -decreased clearance -of the factor in serum and liver (Figure 8a,b) .
Discussion The heparin-binding sites and receptor-binding sites of HGF/SF
Previous studies had shown that the small hairpin structure of the amino-terminal domain of HGF/SF is critical for binding to both heparin [24] and the Met receptor [25, [27] [28] . In this study, we have shown that the binding sites for heparin and the receptor in HGF/SF can be separated by protein engineering and that mutant forms of HGF/SF that have much lower levels of heparin binding also have higher biological activity than wt-HGF/SF in vivo (Figure 8c ). Given that both the HP1 (R73E, R76E, R93E) and HP2 (R73E, R76E, K78E) mutants had a much lower affinity for heparin but had biological activities on target cells in culture that were comparable to wt-HGF/SF, we suggest that the mutations shared by these mutants (R73E and R76E) are critical for heparin binding, a conclusion supported by preliminary characterisation of the R73E,R76E double mutant (G.H., unpublished observations). In contrast, substitution of a second cluster of positively charged residues in the hairpin structure (K91, R93 and K94) or substitution of a separate cluster of positively charged residues in kringle 2 (H241, R242, K244 and R249) abolished both heparin binding and HGF/SF signalling in target cells.
Alanine-scanning mutagenesis of the amino-terminal domain of HGF/SF failed to identify residues in the hairpin structure that are essential for Met binding and signalling [36] , possibly because multiple substitutions of neighbouring residues in the hairpin structure (such as the ones that we have introduced) are required to produce measurable changes: heparin-binding activity was not reported in these studies. Another recent study in which either R76 and R78 or K91, R93 and K94 were mutated to alanine residues showed a modest effect on the heparinbinding activity of the R76A,R78A mutant and no effect for the K91A,R93A,K94A mutant [37] . It should be noted, however, that in this study the critical R73 residue was not mutated and positively charged residues were changed to alanine rather than to negatively charged residues. These features most certainly account for the different behaviour of the set of mutants reported by Sakata and colleagues [37] and the ones described here, and these aspects strengthen the emerging role of electrostatic interactions on association rates [38] .
Binding kinetics of wt-HGF/SF and its NK2 fragment to heparin
Our data indicate that full-length wt-HGF/SF binds heparin with high affinity (K d =~1 nM). This figure compares with a value of 50 nM for acidic FGF obtained under similar experimental conditions [39] . In order to ensure that the measured kinetics resulted from the interaction of monomeric protein species with heparin (and thus establish accurate kinetics for the HP1 mutant), we used monomeric NK2 fragments expressed in P. pastoris. The dissociation kinetics of wt-NK2 revealed a significant effect on apparent k off values at the highest concentrations of protein, suggesting co-operative binding of NK2 to heparin (data not shown). Analysis of the stoichiometry of binding at or near saturation indicated that approximately four wt-NK2 molecules bound 16 kDa heparin. This value suggests that the heparin-binding site of NK2 and HGF/SF encompasses approximately 14 monosaccharide units, which is consistent with the findings of Lyon et al. [40] , who reported that heparan sulphate fragments of 12-14 units were required for high-affinity binding to HGF/SF.
Different roles for heparan sulphates in the HGF/SF and FGF systems
The HP1 mutant has provided a number of insights into the role of heparin-binding in HGF/SF activity. HGF/SF is one of a number of growth factors that bind HSPGs, but the role of heparan sulphate in growth factor activity is generally not clear except in the case of FGF. For FGF there is evidence that three components (ligand, receptor and heparan sulphate) are required for signalling. This conclusion is supported by transfection experiments [2, 3] and biochemical studies with purified components [41] . HSPGs probably act by inducing the dimerisation of FGF thus promoting receptor dimerisation and signalling [42] , an interpretation consistent with the recent structures of FGF-heparin complexes [31] .
Our results indicate a different role for HSPGs in the HGF/SF system. Although two studies have reported that heparin enhances the activity of NK1 and NK2 fragments on cells in culture [33, 37] , we find that the biological activity of a mutant that lacks high-affinity HSPG-binding ability is essentially indistinguishable from wt-HGF/SF. This result is consistent with data demonstrating that fulllength HGF/SF can mediate a substantial mitogenic response in cells, such as BaF3, that lack HSPGs [33] and suggest that, whereas NK1 and NK2 fragments may require HSPGs for agonistic activity [33, 37] , this is not the case for full-length HGF/SF.
Our results, however, do raise the question of the physiological function of HGF/SF binding to HSPGs. The in vivo data presented here suggest a role for HSPGs in promoting the internalisation and degradation of HGF/SF in tissues (Figure 8a,b) . HSPGs may therefore represent a means of clearing HGF/SF in vivo: indeed, there is a striking parallel between the increased DNA synthesis activity of HP1 in liver (Figure 8c ) and the increased level of factor in the tissue (Figure 8b ). It is possible to speculate on other roles for HSPGs. For example, HSPGs may help to localise HGF/SF to selected cell or tissue compartments, as required for the establishment of a 'morphogen gradient' during embryogenesis [43, 44] . An example of this process may be the developing limb, where migration of myogenic precursor cells in the bud is known to depend critically on HGF/SF and Met [45] . Membrane and matrix HSPGs may also provide a storage compartment for HGF/SF.
Applications of heparin-deficient HGF/SF mutants in vivo
Considerable interest has recently arisen in potential therapeutic applications of HGF/SF because the factor promotes liver [46] and kidney [47] regeneration after injury. HGF/SF is cleared very rapidly from the circulation [23, 34, 35] . The half-life of the growth factor in plasma can be extended by binding it to either heparin [23] or other polyanions, such as dextran sulphates [48] , however, and HGF/SF infused as a complex with dextran sulphate has significantly higher activity in inducing hepatocyte proliferation in adult animals [48] . Our work demonstrates that equal or superior results can be achieved with engineered forms of HGF/SF, such as the HP1 mutant. The mutant is present in the circulation for a longer amount of time (Figure 8a ), is present in tissues at greater levels ( Figure  8b ) and is more active than wt-HGF/SF in inducing DNA synthesis in adult liver (Figure 8c ). Mutants such as HP1 may thus extend and enhance the therapeutic applications of HGF/SF.
Materials and methods
Cell lines
Cell lines were either purchased from ATCC or are as previously described in [7] and [49] . Cells were routinely grown in DMEM supplemented with 10% fetal calf serum at 37°C and 10% CO 2 .
In vitro mutagenesis of the hairpin structure and kringle 2
A double stranded oligonucleotide (5′-CACAGTCAGGACATCAT-CATCATCATCATTAAGGATCCTCTAGAGGTAC-3′) coding for six histidine residues and a stop codon was cloned into the KpnI restriction site of the 2.2 kb BamHI-KpnI fragment of the HGF/SF cDNA. In initial experiments, a cDNA encoding wt-HGF/SF fused to a carboxyterminal haemagglutinin tag was used [26] . For the generation of point mutants of the hairpin structure or kringle 2, codon substitutions were introduced into the cDNA by annealing mismatched primers in PCR reactions. The PCR fragments were cloned into the cDNA and mutations confirmed by sequencing. The point mutants generated in this way are shown in Figure 1 . For deletion of the hairpin structure, an additional PstI restriction site was created at nucleotide 300 and a fragment coding for amino acids 68-100 of HGF/SF was deleted by partial digestion.
Transient expression of wild-type and mutant HGF/SF in Neuro 2a cells
The cDNAs encoding mutant HGF/SFs (10 µg each) were transiently transfected into Neuro 2a cells as described [26] . For immunoprecipitation, the Neuro 2a cells were labelled overnight with 20 µCi/ml [ 35 S]cysteine (Amersham) 1 day after transfection, and HGF/SF was immunoprecipitated from the supernatant (1.5 ml) using 2 µg anti-HGF/SF antibody (clone 34) and 100 µl protein A-Sepharose 4B beads. The precipitate was washed three times with 50 mM Tris-Cl pH 8.5, 100 mM NaCl, 1 mM EDTA, 1 mg/ml ovalbumin and 5 g/l Triton X-100 and used for SDS gel electrophoresis and phosphoimager analysis.
Expression of full-length wt-HGF/SF and HP1 in insect cells
For large-scale production of wt-HGF/SF and HP1, the corresponding cDNAs were fused to a carboxy-terminal histidine tag and cloned into the baculovirus expression vector pVL1393. Recombinant virus was generated by co-transfection of 2 µg expression plasmid and 0.5 µg Baculogold-DNA (Pharmingen), plaque-purified, propagated and used to infect 5 l batches of Sf9 cells. The wt-HGF/SF and HP1 proteins were purified from the supernatant after extensive dialysis against PBS and affinity chromatography on 5 ml Ni 2+ -chelate columns (Qiagen) using a linear gradient of imidazole (0-0.4 M in 0.1 M NaCl, 50 mM MES pH 6.0) followed by cation exchange chromatography [8] . The purity of the preparations was typically 80-90% as assessed by Coomassie-stained SDS gels.
Expression of wt-NK2 and HP1-NK2 in P. pastoris
The cDNAs encoding wt-NK2 or HP1-NK2 were generated by PCR amplification of regions of human HGF/SF cDNA and were cloned into the P. pastoris expression vector pPIC 9K (Invitrogen) creating an inframe fusion with the α-mating signal peptide of Saccharomyces cerevisiae. Linearised, recombinant pPIC 9K plasmids carrying wt-NK2 or HP1-NK2 cDNAs were used for transformation of the GS115, hisstrain of P. pastoris by spheroplasting. Transformed clones were initially selected on his -plates and on G418 plates for multicopy integration [50] and selected clones used for large-scale expression. The wt-NK2 fragment was purified on heparin-Sepharose 4B (Pharmacia) followed by S-Sepharose (Pharmacia) using a gradient of NaCl (0.25-1.00 M) in 0.05 M MES, pH 6.0. HP1-NK2 was purified on S-Sepharose. Monomer and dimer species of wt-NK2 and HP1-NK2 were separated by size-exclusion chromatography on a Superdex-75 column (Pharmacia) in 0.05 MES, 0.25 M NaCl, buffer, pH 6.0. The yield of biologically active protein was between 5-10 mg/l.
Heparin and Met ELISAs
For heparin enzyme-linked immunosorbent assay (ELISA), 200 µl high molecular weight heparin (200 µg/ml; Sigma) was added to each well of a 96-well plate (Nunc, Multisorp). Purified HGF/SF and supernatants of Neuro 2a cells expressing wild-type and mutant HGF/SF proteins were incubated for 2 h and detected with either the rabbit anti-histidine tag antibody HA11 (Hiss diagnostics) or with an anti-HGF/SF mouse monoclonal antibody (clone 34) followed by incubation with horseradish peroxidase (HRP)-conjugated second antibody. For Met ELISA, a soluble fusion protein consisting of the extracellular domain(s) of Met and the hinge, CH2 and CH3 domain of immunoglobulin γ1 was produced (G.H., unpublished observations) and purified by protein A-Sepharose affinity chromatography to approximately 80% homogeneity. After coating with full-length wt-HGF/SF or HP1 overnight at 4°C, the Met-Fc fusion protein was added (200 ng/ml) for 2 h followed by incubation with goat anti-human IgG antibody and HRP-conjugated rabbit anti-goat IgG antibody. For colour development, 0.66 mg/ml ortho-phenyl diamine in 50 mM phospate buffer pH 6.0 was used as an HRP substrate (100 µl/well).
Heparin-binding kinetics of full-length wt-HGF/SF and HP1 and their NK2 fragments
Kinetic analysis of the binding of wild-type and mutant proteins was carried out by SPR using a BIAcore 2000 instrument. High molecular weight heparin (10 mg/ml; Sigma) was biotinylated with a 3-fold excess of NHS-LC-biotin (Pierce) in 1 ml of 100 mM phosphate buffer pH 8.0 for 1 h at room temperature. Biotinylated heparin was used for capture on the surface of streptavidin-coated SA sensor chips. All experiments were carried out at an operating temperature of 25°C using PBS, 0.2 mM EDTA, 0.5 g/l NaN 3 , 0.05 g/l p20 detergent (BIAcore) as running buffer (EB) at 15 µl/min. Samples were routinely diluted in 0.2 mg/ml bovine serum albumin (BSA) in 0.2 mM EDTA that had been pre-absorbed onto heparin-Sepharose4B (Pharmacia). Regeneration of the surface was carried out with 10 µl 0.1 g/l SDS in water followed by 2 × 10 µl 1 M NaCl. Finally, 15 µl 0.2 mg/ml BSA in EB was injected to block any non-specific binding sites. Data files from the automated analysis runs were analysed by non-linear curve fitting [51] using the BIAcore BIAevaluation software. Protein concentrations were measured by the BCA reagent (Pierce) and the biological activity of each batch of protein confirmed in the MDCK assay [7] .
Cell biological assays
Colony scatter assays of MDCK and mink lung cells were carried out as previously described [7] . For measurement of DNA synthesis, mink lung cells were plated at a density of 5,000-10,000 cells/well in a 24-well plate and serum-starved by incubation in DMEM for 48 h. Different concentrations of HGF/SF and HP1 were added and incubation continued for 24 h in DMEM containing 100 µg/ml BSA before addition of [ 3 H]-thymidine (1 µCi/well) and a further incubation for 16 h. Radioactivity that was insoluble in 5% TCA was measured by scintillation counting after solubilisation in 0.2 M NaOH.
Total binding of wt-HGF/SF and HP1 to mink lung, HepG2 and Hep3B cells
Mink lung cells were grown to confluence in 24-well plates. After two washes with medium, cells were incubated at 4°C for 30 min. Serial dilutions of HGF/SF and HP1 in PBS were then added to the cells and the cells were then incubated for 60 min at 4°C. Unbound factor was removed by three washes with PBS and cells fixed with 4% paraformaldheyde in PBS. After two further washes, the cells were incubated for 15 min with a mouse anti-HGF/SF monoclonal antibody (clone 34), which reacted in an identical manner with wt-HGF/SF and HP1, followed by incubation for a further 15 min with fluorescein isothiocyanate-conjugated anti-mouse IgG. A similar procedure was followed for measuring the total binding of wt-HGF/SF and HP1 to HepG2 and Hep3B cells except that the cells were cultured in dishes instead of 24-well plates and binding was assessed by fluorescence microscopy.
Clearance and tissue distribution of wt-HGF/SF and HP1 in rats
Pure HGF/SF and HP1 (10 µg) were iodinated by a solid-phase method using Iodogen (Pierce) by Biotez. After the reaction, 1 mg/ml BSA was added and free iodine was removed by multiple filtration on a Centrisat filtration apparatus (Sartorius) with a 30 kDa cut-off point. The specific activities were calculated to be 1.85 MBq/mg for HGF/SF and 1.95 MBq/mg for HP1. The biological activities of the proteins before and after iodination was compared in a motility assay using MDCK cells and determined to be 80% after iodination. Adult rats (three per group) were anaesthetised, a catheter implanted into the jugular vein and a single intravenous bolus injection of 0. 
Effect of wt-HGF/SF and HP1 on DNA synthesis in adult liver
The ability of wild-type HGF/SF and HP1 to induce DNA synthesis in liver cells was measured following intravenous administration of recombinant proteins and cell labelling with BrdU. Briefly, female animals (6-8 weeks old; 19.5-26.9 g body weight) were injected twice daily with either PBS, wild-type HGF/SF or HP1 in the tail vein (55.5 µg/dose) for three days. At the time of the last injection of factor, each animal received BrdU (75 µg/g body weight) was injected intraperitoneally and 12 h later the animals were sacrificed, the liver was dissected and frozen sections were prepared. Sections were fixed in 70% ethanol (5 min), treated with 2.4 M HCl for 10 min at 37°C and nuclei that had incorporated BrdU were stained with anti-BrdU antibody (Sigma, 1:400) followed by peroxidase-conjugated anti-mouse IgG (Jackson Laboratories, 1:500).
Supplementary material available
A figure showing BIAcore analysis of wt-HGF/SF and HP1 binding to immobilised heparin is published with this paper on the internet. 
